<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8526725</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">34690670</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">8526725</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fnins.2021.707675</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Clinical and experimental characteristics of the studies.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T1"><label>Table 1</label><caption><p>Clinical and experimental characteristics of the studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Study design</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Experimental treatment setting</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Control treatment setting</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Session duration and frequency</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Clinical outcomes</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="7" rowspan="1"><bold>Upper limb rehabilitation</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rocca et al. (<xref rid="B62" ref-type="bibr">2019</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 20 MS, 23 HC <break/>Con = 21 MS, 23 HC</td><td valign="top" align="left" rowspan="1" colspan="1">Physiotherapist supervised sessions comprising <break/>10 min of right upper limb passive mobilization + 30 min AOT (viewing videos and executing “daily life right hand and arm actions”)</td><td valign="top" align="left" rowspan="1" colspan="1">Physiotherapist supervised sessions comprising <break/>10 min of right upper limb passive mobilization + 30 min viewing videos on “inanimate landscapes ” and executing “daily life right hand and arm actions”</td><td valign="top" align="left" rowspan="1" colspan="1">HC = 40 min <break/>MS = 80 min <break/>2 weeks (5 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1">Hand muscle strength (<bold>Jamar</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref> and Pinch dynamometer); 9HPT; Functional independent measure (1–7); <bold>PASAT-3</bold>; Finger Tapping Frequency</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Barghi et al. (<xref rid="B2" ref-type="bibr">2018</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 10 <break/>Con = 10</td><td valign="top" align="left" rowspan="1" colspan="1">Outpatient and home-based settings. The CIMT session comprised intensive training of the most affected arm, training by the behavioral technique termed shaping, transfer of behavioral procedure to improve everyday life situation and reducing the use of the less affected arm by wearing of heavily padded restraining mitt for 90% of waking hour</td><td valign="top" align="left" rowspan="1" colspan="1">Outpatient and home-based settings. The CAM session consisted of relaxation exercise, aquatic therapy, massage, music therapy and yoga</td><td valign="top" align="left" rowspan="1" colspan="1">210 min <break/>2 weeks (5 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Motor Activity Log</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref><bold>;</bold> Wolf Motor Function Test</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bonzano et al. (<xref rid="B9" ref-type="bibr">2014</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 15 <break/>Con = 15</td><td valign="top" align="left" rowspan="1" colspan="1">Physiotherapist supervised sessions of active task-oriented training to improve proprioceptive sensibility, muscle strength, stability, and coordination. The percentage of treatment time involving bimanual rather than unilateral tasks increased from 6th to 12th sessions to reach 100%</td><td valign="top" align="left" rowspan="1" colspan="1">Physiotherapist-delivered sessions consisting of passive mobilization of upper limbs joints. The same scheme of the active treatment was used for unilateral and bilateral mobilization</td><td valign="top" align="left" rowspan="1" colspan="1">60 min <break/>8 weeks (3 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>ARAT</bold>; <bold>9HPT</bold>; <bold>GRIP</bold>; With the use of an engineered glove finger motor performance accuracy was quantified in terms of <bold>movement rate</bold> at spontaneous (SV) and maximum velocity <bold>(MV)</bold> and (for bimanual task) inter hand interval (<bold>IHI</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref><bold>)</bold> as an index of bimanual coordination</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bonzano et al. (<xref rid="B8" ref-type="bibr">2019</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 15 <break/>Con = 15</td><td valign="top" align="left" rowspan="1" colspan="1">Physiotherapist supervised sessions of active task-oriented training to improve proprioceptive sensibility, muscle strength, stability and coordination. The percentage of treatment time involving bimanual rather than unilateral tasks increased from 6th to 12th sessions to reach 100%</td><td valign="top" align="left" rowspan="1" colspan="1">Physiotherapist-delivered sessions consisting of passive mobilization of upper limbs joints. The same scheme of the active treatment was used for unilateral and bilateral mobilization</td><td valign="top" align="left" rowspan="1" colspan="1">60 min <break/>8 weeks (3 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>GRIP</bold>; ARAT; <bold>9HPT</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Boffa et al. (<xref rid="B7" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 13 <break/>Cont = 13</td><td valign="top" align="left" rowspan="1" colspan="1">Physiotherapist supervised sessions of active task-oriented training to restore or acquire skills. Unimanual and bimanual tasks were differently weighted in each session and the percentage of time dedicate to bimanual tasks increased from the 7th to the 36th sessions to reach 100%</td><td valign="top" align="left" rowspan="1" colspan="1">Physiotherapist-delivered sessions consisting of passive mobilization of upper limbs. The same scheme of the active treatment was used for unilateral and bilateral mobilization</td><td valign="top" align="left" rowspan="1" colspan="1">60 min <break/>9 weeks (2 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1">EDSS; ARAT; 9HPT; ABILHAND scale; <bold>MFIS (total and physical subscales)</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; With the use of an engineered glove finger motor performance accuracy was quantified in terms of movement rate at spontaneous (<bold>SV</bold>) and maximum velocity (<bold>MV</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>) and (for bimanual task) inter hand interval (<bold>IHI</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>) as an index of bimanual coordination</td></tr><tr><td valign="top" align="left" colspan="7" rowspan="1"><bold>Lower limb rehabilitation</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stellmann et al. (<xref rid="B70" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 34 MS <break/>Con = 34 MS</td><td valign="top" align="left" rowspan="1" colspan="1">Outpatient setting. Aerobic exercise involving the use of a bicycle ergometer with pedaling rate tailored on the level of physical fitness of each patient</td><td valign="top" align="left" rowspan="1" colspan="1">No training (waitlist)</td><td valign="top" align="left" rowspan="1" colspan="1">10–100 min <break/>12 weeks (3 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1">Primary outcome: VLMT <break/>Secondary outcome: EDSS; SDMT; PASAT; Phasic alertness; Tonic alertness; Digits forwards; T25FW; 6MWT; <bold>9HPT</bold>; VO2_peak; VO2 max/kg</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tavazzi et al. (<xref rid="B74" ref-type="bibr">2018</xref>)<xref rid="TN2" ref-type="table-fn"><sup>§</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 26</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatient setting consisting of exercises for global physical functioning and either endurance or progressive resistance training <break/>Resistance training was administered using elastic bands and weights. The endurance training involved the use of a treadmill to improve balance and gait adaptability</td><td valign="top" align="left" rowspan="1" colspan="1">–</td><td valign="top" align="left" rowspan="1" colspan="1">60–90 min <break/>4 weeks <break/>(5 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1">EDSS; <bold>2MWT</bold>; T25FW; <bold>BBS</bold>; Dynamic gait index; MFIS; MS walking scale-12 items</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kjolhede et al. (<xref rid="B34" ref-type="bibr">2018</xref>)<xref rid="TN2" ref-type="table-fn"><sup>§</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 17 <break/>Con = 12</td><td valign="top" align="left" rowspan="1" colspan="1">Physiotherapist supervised sessions of progressive resistance training consisting of 4 lower body and 2 upper body exercises. The intensity (number of repetitions) of exercises increased during the weeks</td><td valign="top" align="left" rowspan="1" colspan="1">No training (waitlist)</td><td valign="top" align="left" rowspan="1" colspan="1">60–90 min <break/>Duration of the sessions increased during the weeks. <break/>24 weeks (2 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>EDSS</bold>; MSFC: <bold>Total</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref> and <bold>T25FW</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>, 9HPT<xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>, PASAT; MSIS (physical and psychological subscales); 2MWT; 5-Time Sit-To-Stand Test; muscle strength (<bold>maximal voluntary contractions</bold>)<xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ibrahim et al. (<xref rid="B28" ref-type="bibr">2011</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">CC</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 11 MS <break/>HC = 11</td><td valign="top" align="left" rowspan="1" colspan="1">Physiotherapist supervised sessions of facilitation physiotherapy comprising sensorimotor stimuli applied repetitively in standard position and motor functions</td><td valign="top" align="left" rowspan="1" colspan="1">–</td><td valign="top" align="left" rowspan="1" colspan="1">120 min <break/>8 weeks (2 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>PASAT-3</bold>; EDSS</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prosperini et al. (<xref rid="B57" ref-type="bibr">2014</xref>)<xref rid="TN2" ref-type="table-fn"><sup>§</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 34 MS (17–17 cross-over) <break/>HC = 15</td><td valign="top" align="left" rowspan="1" colspan="1">Home based balance training performed using a video game balance board system.</td><td valign="top" align="left" rowspan="1" colspan="1">–</td><td valign="top" align="left" rowspan="1" colspan="1">30 min <break/>12 weeks (1 day/week)</td><td valign="top" align="left" rowspan="1" colspan="1">Force platform–based measures of static standing balance<xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; 4SST; T25FW<xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; MSIS-29<xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fling et al. (<xref rid="B18" ref-type="bibr">2019</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 20 <break/>Con = 20</td><td valign="top" align="left" rowspan="1" colspan="1">Outpatient setting. The patient underwent an Assistive Device Selection, Training, and Education Program (ADSTEP) consisting of walking training. Participants performed progressive task-oriented training walking with an aid-device under varying conditions</td><td valign="top" align="left" rowspan="1" colspan="1">No treatment (waitlist)</td><td valign="top" align="left" rowspan="1" colspan="1">40 min <break/>2 weeks (1 day/week)</td><td valign="top" align="left" rowspan="1" colspan="1">Primary: Self-Reported Falls <break/>Secondary: TUG; 2MWT; T25FW; 4SST; <bold>International Physical Activity Questionnaire</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; Quebec User Evaluation of Satisfaction with Assistive Technologies; Multiple Sclerosis Walking Scale-12; Activities-Specific Balance Confidence Scale; MSIS-29</td></tr><tr><td valign="top" align="left" colspan="7" rowspan="1"><bold>Multimodal rehabilitation</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rasova et al. (<xref rid="B59" ref-type="bibr">2005</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">CC</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 17 MS <break/>Con = 11 MS <break/>HC = 13</td><td valign="top" align="left" rowspan="1" colspan="1">Outpatient setting. Sessions of “rehabilitative eclectic therapy based on principle of sensorimotor learning and adaptation”</td><td valign="top" align="left" rowspan="1" colspan="1">No treatment</td><td valign="top" align="left" rowspan="1" colspan="1">60 min <break/>8 weeks (2 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>T25FW</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; <bold>9HPT</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; <bold>PASAT-3</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; <bold>PR</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref><bold>; MFIS</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; <bold>BDIS</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; BI; environmental status scale; <bold>MS QoL</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prochazkova et al. (<xref rid="B56" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 20 MS <break/>Con = 18 MS <break/>HC = 42</td><td valign="top" align="left" rowspan="1" colspan="1">Outpatient setting physiotherapist supervised consisting of experimental neuro-proprioceptive facilitation, inhibition intervention: Motor program activating therapy that combines proprioceptive, tactile, visual and auditory stimuli</td><td valign="top" align="left" rowspan="1" colspan="1">Outpatient setting consisting of standard neuro-proprioceptive facilitation, inhibition intervention: Vojta reflex locomotion with stimulation of “initiation zone”</td><td valign="top" align="left" rowspan="1" colspan="1">60 min <break/>8 weeks (2 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1">Primary outcome: MRI data <break/>Secondary outcome: 9HPT; PASAT; BBS; T25FW; TUG</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rasova et al. (<xref rid="B60" ref-type="bibr">2015</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">CS</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 12</td><td valign="top" align="left" rowspan="1" colspan="1">Outpatient setting physiotherapist supervised sessions of experimental neuro-proprioceptive facilitation, inhibition intervention: Motor program activating therapy that combines proprioceptive, tactile, visual and auditory stimuli</td><td valign="top" align="left" rowspan="1" colspan="1">–</td><td valign="top" align="left" rowspan="1" colspan="1">60 min <break/>8 weeks (2 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1">Motricity Index; <bold>Modified Ashworth Scale</bold>; BBS; <bold>Tremor</bold>; <bold>dysdiadochokinesis</bold>; <bold>dysmetria</bold>; PASAT-3; <bold>9HPT</bold>; <bold>T25FW</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Akbar et al. (<xref rid="B1" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Semi-RCT</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 5 <break/>Con = 5</td><td valign="top" align="left" rowspan="1" colspan="1">Mostly home-based training in combination with outpatient setting <break/>The progressive resistance training involved exercise targeting large muscle groups of upper and lower limbs. The intensity/difficulty of exercises increased during the training session.</td><td valign="top" align="left" rowspan="1" colspan="1">Mostly home-based training in combination with outpatient setting <break/>Stretching sessions developed following the “Stretching for people with MS” manual.</td><td valign="top" align="left" rowspan="1" colspan="1">120 min <break/>16 weeks (3 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1">MFIS<xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref> (total score and subscales for physical, cognitive and psychosocial impact); T25FW; Godin Leisure-Time Exercise Questionnaire; GRIP</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zuber et al. (<xref rid="B85" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Longitudinal PG</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 24 MS <break/>HC = 24</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatient setting. Personalized multidisciplinary rehabilitation</td><td valign="top" align="left" rowspan="1" colspan="1">–</td><td valign="top" align="left" rowspan="1" colspan="1">100 min <break/>3 weeks <break/>program mean duration: 16.6 ± 3.2 days (min = 10, max = 25.5 days) <break/>Session mean duration: 46.1 ± 15.3 h (min = 26.5, max = 80.6 h)</td><td valign="top" align="left" rowspan="1" colspan="1"><bold>PASAT</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; SDMT; <bold>digit span</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref> (WAIS-IV); Corsi Block Tapping Test; health-related QoL questionnaire (<bold>SF-12</bold>)<xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>;<bold>FSMC motor component</bold>; <bold>9HPT</bold><xref rid="TN1" ref-type="table-fn"><sup>†</sup></xref>; <bold>T25FW</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Peran et al. (<xref rid="B51" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">SCCS</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 26</td><td valign="top" align="left" rowspan="1" colspan="1">Inpatient setting. Personalized multidisciplinary rehabilitation which could include: physical therapy, occupational therapy, hydrokinetic therapy, cognitive therapy, therapies for speech, swallowing, respiration and ocular movements</td><td valign="top" align="left" rowspan="1" colspan="1">–</td><td valign="top" align="left" rowspan="1" colspan="1">135 min <break/>10 weeks (6 days/week)</td><td valign="top" align="left" rowspan="1" colspan="1">EDSS; <bold>MSIS-29</bold>; FSS; <bold>BI</bold>; BDIS; <bold>RMI</bold></td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">2/6 MWT, 2/6 min walking test; 4SST, 4-step square test; 9HPT, 9-hole peg test; AOT, action observation training; ARAT, action research arm test; BBS, Berg balance scale; BDIS, Beck depression inventory score; BI, Barthel Index; CAM, Complementary and Alternative Medicine; CC, case control; CIMT, constraint induced movement therapy; Con, control group; EDSS, Expanded Disability Status Scale; FSMC, fatigue scale for motor and cognitive function; FSS, Krupp's Fatigue Severity Scale; GRIP, grip strength by a dynamometer; HC, healthy controls; Int, intervention group; MS, multiple sclerosis; MFIS, Modified fatigue impact scale; MSIS, MS impact scale; PASAT, paced auditory serial addition test; PG, parallel group; PR, postural reaction; QoL, Quality of Life; RCT, randomized controlled trial; RMI, Rivermead Mobility Index; SCCS-self-controlled case series; SDMT, symbol digit modality test; TUG, Timed up and go; T25FW, timed 25 foot walk; VLMT, verbal learning and memory test</italic>.</p><p><italic toggle="yes">In bold character are reported the outcome measures with a significant post-vs. pre-treatment effect</italic>.</p><fn id="TN1"><label>†</label><p><italic toggle="yes">Significant effect for the interventional group compared to the control group</italic>.</p></fn><fn id="TN2"><label>§</label><p><italic toggle="yes">The study has an additional timepoint, after the end of the rehabilitation treatment or during it, in randomized crossover trials</italic>.</p></fn><p><italic toggle="yes">Subjects are reported as follows: in case of studies comparing the efficacy of an experimental rehabilitation treatment with conventional physiotherapy, or with no physical activity of any sort, the first group is indicated as “Int” (intervention) and the second as “Con” (control)</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Clinical and experimental characteristics of the studies.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">References</th><th valign="top" align="left">Study design</th><th valign="top" align="left">Subjects</th><th valign="top" align="left">Experimental treatment setting</th><th valign="top" align="left">Control treatment setting</th><th valign="top" align="left">Session duration and frequency</th><th valign="top" align="left">Clinical outcomes</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="7">Upper limb rehabilitation</td></tr><tr><td valign="top" align="left">Rocca et al. (???)</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 20 MS, 23 HC Con = 21 MS, 23 HC</td><td valign="top" align="left">Physiotherapist supervised sessions comprising 10 min of right upper limb passive mobilization + 30 min AOT (viewing videos and executing “daily life right hand and arm actions”)</td><td valign="top" align="left">Physiotherapist supervised sessions comprising 10 min of right upper limb passive mobilization + 30 min viewing videos on “inanimate landscapes ” and executing “daily life right hand and arm actions”</td><td valign="top" align="left">HC = 40 min MS = 80 min 2 weeks (5 days/week)</td><td valign="top" align="left">Hand muscle strength (Jamar??? and Pinch dynamometer); 9HPT; Functional independent measure (1–7); PASAT-3; Finger Tapping Frequency</td></tr><tr><td valign="top" align="left">Barghi et al. (???)</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 10 Con = 10</td><td valign="top" align="left">Outpatient and home-based settings. The CIMT session comprised intensive training of the most affected arm, training by the behavioral technique termed shaping, transfer of behavioral procedure to improve everyday life situation and reducing the use of the less affected arm by wearing of heavily padded restraining mitt for 90% of waking hour</td><td valign="top" align="left">Outpatient and home-based settings. The CAM session consisted of relaxation exercise, aquatic therapy, massage, music therapy and yoga</td><td valign="top" align="left">210 min 2 weeks (5 days/week)</td><td valign="top" align="left">Motor Activity Log???; Wolf Motor Function Test</td></tr><tr><td valign="top" align="left">Bonzano et al. (???)</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 15 Con = 15</td><td valign="top" align="left">Physiotherapist supervised sessions of active task-oriented training to improve proprioceptive sensibility, muscle strength, stability, and coordination. The percentage of treatment time involving bimanual rather than unilateral tasks increased from 6th to 12th sessions to reach 100%</td><td valign="top" align="left">Physiotherapist-delivered sessions consisting of passive mobilization of upper limbs joints. The same scheme of the active treatment was used for unilateral and bilateral mobilization</td><td valign="top" align="left">60 min 8 weeks (3 days/week)</td><td valign="top" align="left">ARAT; 9HPT; GRIP; With the use of an engineered glove finger motor performance accuracy was quantified in terms of movement rate at spontaneous (SV) and maximum velocity (MV) and (for bimanual task) inter hand interval (IHI???) as an index of bimanual coordination</td></tr><tr><td valign="top" align="left">Bonzano et al. (???)</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 15 Con = 15</td><td valign="top" align="left">Physiotherapist supervised sessions of active task-oriented training to improve proprioceptive sensibility, muscle strength, stability and coordination. The percentage of treatment time involving bimanual rather than unilateral tasks increased from 6th to 12th sessions to reach 100%</td><td valign="top" align="left">Physiotherapist-delivered sessions consisting of passive mobilization of upper limbs joints. The same scheme of the active treatment was used for unilateral and bilateral mobilization</td><td valign="top" align="left">60 min 8 weeks (3 days/week)</td><td valign="top" align="left">GRIP; ARAT; 9HPT</td></tr><tr><td valign="top" align="left">Boffa et al. (???)</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 13 Cont = 13</td><td valign="top" align="left">Physiotherapist supervised sessions of active task-oriented training to restore or acquire skills. Unimanual and bimanual tasks were differently weighted in each session and the percentage of time dedicate to bimanual tasks increased from the 7th to the 36th sessions to reach 100%</td><td valign="top" align="left">Physiotherapist-delivered sessions consisting of passive mobilization of upper limbs. The same scheme of the active treatment was used for unilateral and bilateral mobilization</td><td valign="top" align="left">60 min 9 weeks (2 days/week)</td><td valign="top" align="left">EDSS; ARAT; 9HPT; ABILHAND scale; MFIS (total and physical subscales)???; With the use of an engineered glove finger motor performance accuracy was quantified in terms of movement rate at spontaneous (SV) and maximum velocity (MV???) and (for bimanual task) inter hand interval (IHI???) as an index of bimanual coordination</td></tr><tr><td valign="top" align="left" colspan="7">Lower limb rehabilitation</td></tr><tr><td valign="top" align="left">Stellmann et al. (???)</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 34 MS Con = 34 MS</td><td valign="top" align="left">Outpatient setting. Aerobic exercise involving the use of a bicycle ergometer with pedaling rate tailored on the level of physical fitness of each patient</td><td valign="top" align="left">No training (waitlist)</td><td valign="top" align="left">10–100 min 12 weeks (3 days/week)</td><td valign="top" align="left">Primary outcome: VLMT Secondary outcome: EDSS; SDMT; PASAT; Phasic alertness; Tonic alertness; Digits forwards; T25FW; 6MWT; 9HPT; VO2_peak; VO2 max/kg</td></tr><tr><td valign="top" align="left">Tavazzi et al. (???)???</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 26</td><td valign="top" align="left">Inpatient setting consisting of exercises for global physical functioning and either endurance or progressive resistance training Resistance training was administered using elastic bands and weights. The endurance training involved the use of a treadmill to improve balance and gait adaptability</td><td valign="top" align="left">–</td><td valign="top" align="left">60–90 min 4 weeks (5 days/week)</td><td valign="top" align="left">EDSS; 2MWT; T25FW; BBS; Dynamic gait index; MFIS; MS walking scale-12 items</td></tr><tr><td valign="top" align="left">Kjolhede et al. (???)???</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 17 Con = 12</td><td valign="top" align="left">Physiotherapist supervised sessions of progressive resistance training consisting of 4 lower body and 2 upper body exercises. The intensity (number of repetitions) of exercises increased during the weeks</td><td valign="top" align="left">No training (waitlist)</td><td valign="top" align="left">60–90 min Duration of the sessions increased during the weeks. 24 weeks (2 days/week)</td><td valign="top" align="left">EDSS; MSFC: Total??? and T25FW???, 9HPT???, PASAT; MSIS (physical and psychological subscales); 2MWT; 5-Time Sit-To-Stand Test; muscle strength (maximal voluntary contractions)???</td></tr><tr><td valign="top" align="left">Ibrahim et al. (???)</td><td valign="top" align="left">CC</td><td valign="top" align="left">Int = 11 MS HC = 11</td><td valign="top" align="left">Physiotherapist supervised sessions of facilitation physiotherapy comprising sensorimotor stimuli applied repetitively in standard position and motor functions</td><td valign="top" align="left">–</td><td valign="top" align="left">120 min 8 weeks (2 days/week)</td><td valign="top" align="left">PASAT-3; EDSS</td></tr><tr><td valign="top" align="left">Prosperini et al. (???)???</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 34 MS (17–17 cross-over) HC = 15</td><td valign="top" align="left">Home based balance training performed using a video game balance board system.</td><td valign="top" align="left">–</td><td valign="top" align="left">30 min 12 weeks (1 day/week)</td><td valign="top" align="left">Force platform–based measures of static standing balance???; 4SST; T25FW???; MSIS-29???</td></tr><tr><td valign="top" align="left">Fling et al. (???)</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 20 Con = 20</td><td valign="top" align="left">Outpatient setting. The patient underwent an Assistive Device Selection, Training, and Education Program (ADSTEP) consisting of walking training. Participants performed progressive task-oriented training walking with an aid-device under varying conditions</td><td valign="top" align="left">No treatment (waitlist)</td><td valign="top" align="left">40 min 2 weeks (1 day/week)</td><td valign="top" align="left">Primary: Self-Reported Falls Secondary: TUG; 2MWT; T25FW; 4SST; International Physical Activity Questionnaire???; Quebec User Evaluation of Satisfaction with Assistive Technologies; Multiple Sclerosis Walking Scale-12; Activities-Specific Balance Confidence Scale; MSIS-29</td></tr><tr><td valign="top" align="left" colspan="7">Multimodal rehabilitation</td></tr><tr><td valign="top" align="left">Rasova et al. (???)</td><td valign="top" align="left">CC</td><td valign="top" align="left">Int = 17 MS Con = 11 MS HC = 13</td><td valign="top" align="left">Outpatient setting. Sessions of “rehabilitative eclectic therapy based on principle of sensorimotor learning and adaptation”</td><td valign="top" align="left">No treatment</td><td valign="top" align="left">60 min 8 weeks (2 days/week)</td><td valign="top" align="left">T25FW???; 9HPT???; PASAT-3???; PR???; MFIS???; BDIS???; BI; environmental status scale; MS QoL</td></tr><tr><td valign="top" align="left">Prochazkova et al. (???)</td><td valign="top" align="left">RCT</td><td valign="top" align="left">Int = 20 MS Con = 18 MS HC = 42</td><td valign="top" align="left">Outpatient setting physiotherapist supervised consisting of experimental neuro-proprioceptive facilitation, inhibition intervention: Motor program activating therapy that combines proprioceptive, tactile, visual and auditory stimuli</td><td valign="top" align="left">Outpatient setting consisting of standard neuro-proprioceptive facilitation, inhibition intervention: Vojta reflex locomotion with stimulation of “initiation zone”</td><td valign="top" align="left">60 min 8 weeks (2 days/week)</td><td valign="top" align="left">Primary outcome: MRI data Secondary outcome: 9HPT; PASAT; BBS; T25FW; TUG</td></tr><tr><td valign="top" align="left">Rasova et al. (???)</td><td valign="top" align="left">CS</td><td valign="top" align="left">Int = 12</td><td valign="top" align="left">Outpatient setting physiotherapist supervised sessions of experimental neuro-proprioceptive facilitation, inhibition intervention: Motor program activating therapy that combines proprioceptive, tactile, visual and auditory stimuli</td><td valign="top" align="left">–</td><td valign="top" align="left">60 min 8 weeks (2 days/week)</td><td valign="top" align="left">Motricity Index; Modified Ashworth Scale; BBS; Tremor; dysdiadochokinesis; dysmetria; PASAT-3; 9HPT; T25FW</td></tr><tr><td valign="top" align="left">Akbar et al. (???)</td><td valign="top" align="left">Semi-RCT</td><td valign="top" align="left">Int = 5 Con = 5</td><td valign="top" align="left">Mostly home-based training in combination with outpatient setting The progressive resistance training involved exercise targeting large muscle groups of upper and lower limbs. The intensity/difficulty of exercises increased during the training session.</td><td valign="top" align="left">Mostly home-based training in combination with outpatient setting Stretching sessions developed following the “Stretching for people with MS” manual.</td><td valign="top" align="left">120 min 16 weeks (3 days/week)</td><td valign="top" align="left">MFIS??? (total score and subscales for physical, cognitive and psychosocial impact); T25FW; Godin Leisure-Time Exercise Questionnaire; GRIP</td></tr><tr><td valign="top" align="left">Zuber et al. (???)</td><td valign="top" align="left">Longitudinal PG</td><td valign="top" align="left">Int = 24 MS HC = 24</td><td valign="top" align="left">Inpatient setting. Personalized multidisciplinary rehabilitation</td><td valign="top" align="left">–</td><td valign="top" align="left">100 min 3 weeks program mean duration: 16.6 ± 3.2 days (min = 10, max = 25.5 days) Session mean duration: 46.1 ± 15.3 h (min = 26.5, max = 80.6 h)</td><td valign="top" align="left">PASAT???; SDMT; digit span??? (WAIS-IV); Corsi Block Tapping Test; health-related QoL questionnaire (SF-12)???;FSMC motor component; 9HPT???; T25FW</td></tr><tr><td valign="top" align="left">Peran et al. (???)</td><td valign="top" align="left">SCCS</td><td valign="top" align="left">Int = 26</td><td valign="top" align="left">Inpatient setting. Personalized multidisciplinary rehabilitation which could include: physical therapy, occupational therapy, hydrokinetic therapy, cognitive therapy, therapies for speech, swallowing, respiration and ocular movements</td><td valign="top" align="left">–</td><td valign="top" align="left">135 min 10 weeks (6 days/week)</td><td valign="top" align="left">EDSS; MSIS-29; FSS; BI; BDIS; RMI</td></tr></tbody></table></div>2/6 MWT, 2/6 min walking test; 4SST, 4-step square test; 9HPT, 9-hole peg test; AOT, action observation training; ARAT, action research arm test; BBS, Berg balance scale; BDIS, Beck depression inventory score; BI, Barthel Index; CAM, Complementary and Alternative Medicine; CC, case control; CIMT, constraint induced movement therapy; Con, control group; EDSS, Expanded Disability Status Scale; FSMC, fatigue scale for motor and cognitive function; FSS, Krupp's Fatigue Severity Scale; GRIP, grip strength by a dynamometer; HC, healthy controls; Int, intervention group; MS, multiple sclerosis; MFIS, Modified fatigue impact scale; MSIS, MS impact scale; PASAT, paced auditory serial addition test; PG, parallel group; PR, postural reaction; QoL, Quality of Life; RCT, randomized controlled trial; RMI, Rivermead Mobility Index; SCCS-self-controlled case series; SDMT, symbol digit modality test; TUG, Timed up and go; T25FW, timed 25 foot walk; VLMT, verbal learning and memory test.In bold character are reported the outcome measures with a significant post-vs. pre-treatment effect.†Significant effect for the interventional group compared to the control group.§The study has an additional timepoint, after the end of the rehabilitation treatment or during it, in randomized crossover trials.Subjects are reported as follows: in case of studies comparing the efficacy of an experimental rehabilitation treatment with conventional physiotherapy, or with no physical activity of any sort, the first group is indicated as “Int” (intervention) and the second as “Con” (control).</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2</table-label><table-caption>MRI characteristic of the studies and significant results.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T2"><label>Table 2</label><caption><p>MRI characteristic of the studies and significant results.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects included in the MRI study</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>MR sequences</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Post-processing [MRI markers]</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>MRI significant results+</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Brain area of observed changes</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Rocca et al. (<xref rid="B62" ref-type="bibr">2019</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 20 MS, 23 HC Con = 21 MS, HC = 23</td><td valign="top" align="left" rowspan="1" colspan="1">3D T1 TFE</td><td valign="top" align="left" rowspan="1" colspan="1">VBM, TBM [GM volumes]</td><td valign="top" align="left" rowspan="1" colspan="1">Int MS vs. Con MS:↑GM volume <break/>↓GM volume</td><td valign="top" align="left" rowspan="1" colspan="1">L-MOG, L-SFG, R-IFG <break/>SMA</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Int MS: correlation between clinical and volumes</td><td valign="top" align="left" rowspan="1" colspan="1">[R-IFG, R-SFG]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Positive correlation: [R-finger tapping, FIM, L Jamar, R Jamar, PASAT] <break/>Negative correlation: [PASAT]</td><td valign="top" align="left" rowspan="1" colspan="1">[R-SMA]</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">DWI</td><td valign="top" align="left" rowspan="1" colspan="1">TBSS [FA, MD, RD, AD]</td><td valign="top" align="left" rowspan="1" colspan="1">No results</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">RS-fMRI</td><td valign="top" align="left" rowspan="1" colspan="1">Seed-based analyses [FC indices]</td><td valign="top" align="left" rowspan="1" colspan="1">Int MS vs. Con MS: ↑RS FC <break/>Int MS: positive correlation with PASAT</td><td valign="top" align="left" rowspan="1" colspan="1">L/R-cerebellum, R-IFG, R-calcarine sulcus <break/>Motor and MNS network</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Task-fMRI (manipulation task)</td><td valign="top" align="left" rowspan="1" colspan="1">GLM analyses [BOLD maps]</td><td valign="top" align="left" rowspan="1" colspan="1">Int MS vs. Con MS:<break/>↑activation (R hand manipulation) <break/>↑activation (L hand manipulation)</td><td valign="top" align="left" rowspan="1" colspan="1">R/L-IFG, L-insula <break/>L-FG, R-SFG</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Int MS correlations: between clinical and fMRI maps of R hand manipulation [R-finger Tapping, R-Jamar, PASAT]</td><td valign="top" align="left" rowspan="1" colspan="1">R/L-IFG, L-insula, L-angular, L-MTG</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Between clinical and fMRI maps of L hand manipulation [PASAT]</td><td valign="top" align="left" rowspan="1" colspan="1">R-SFG</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Barghi et al. (<xref rid="B2" ref-type="bibr">2018</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 10 <break/>Con = 10</td><td valign="top" align="left" rowspan="1" colspan="1">DWI</td><td valign="top" align="left" rowspan="1" colspan="1">TBSS [FA, MD, RD, AD]</td><td valign="top" align="left" rowspan="1" colspan="1">↑FA</td><td valign="top" align="left" rowspan="1" colspan="1">PCC, SOG</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">↑AD</td><td valign="top" align="left" rowspan="1" colspan="1">STG</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">↓RD, MD</td><td valign="top" align="left" rowspan="1" colspan="1">CST</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Int: correlation between FA and motor improvement</td><td valign="top" align="left" rowspan="1" colspan="1">CC and SOG</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bonzano et al. (<xref rid="B9" ref-type="bibr">2014</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 15 <break/>Con = 15</td><td valign="top" align="left" rowspan="1" colspan="1">DWI</td><td valign="top" align="left" rowspan="1" colspan="1">DTI [FA, MD, RD, AD]</td><td valign="top" align="left" rowspan="1" colspan="1">↓FA</td><td valign="top" align="left" rowspan="1" colspan="1">CC, CST</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">↑RD</td><td valign="top" align="left" rowspan="1" colspan="1">CC, CST</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Bonzano et al. (<xref rid="B8" ref-type="bibr">2019</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 15 <break/>Con = 15</td><td valign="top" align="left" rowspan="1" colspan="1">Task-fMRI (finger tapping)</td><td valign="top" align="left" rowspan="1" colspan="1">GLM analyses [BOLD maps]</td><td valign="top" align="left" rowspan="1" colspan="1">↑activation</td><td valign="top" align="left" rowspan="1" colspan="1">R-cerebellum, L-pre/post-central Gy, L-insula</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Boffa et al. (<xref rid="B7" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 13 <break/>Con = 13</td><td valign="top" align="left" rowspan="1" colspan="1">DWI</td><td valign="top" align="left" rowspan="1" colspan="1">DTI</td><td valign="top" align="left" rowspan="1" colspan="1">No results</td><td valign="top" align="left" rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">RS-fMRI</td><td valign="top" align="left" rowspan="1" colspan="1">Seed-based analysis [FC indices]</td><td valign="top" align="left" rowspan="1" colspan="1">↑FC</td><td valign="top" align="left" rowspan="1" colspan="1">bilateral thalami and R-cerebellum; cerebellar vermis and R-insula; cerebellar vermis and RSTG</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Int: Correlation between clinical and FC [IHI-SV, IHI-MV]</td><td valign="top" align="left" rowspan="1" colspan="1">R-M1 and R-S1; R/L thalami and R/L IFG; R/L-S1 and L-supramarginal Gy</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Stellmann et al. (<xref rid="B70" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 27 MS <break/>Con = 30 MS <break/>HC = 30</td><td valign="top" align="left" rowspan="1" colspan="1">DWI</td><td valign="top" align="left" rowspan="1" colspan="1">Graph based analysis structural connectomics [FA]</td><td valign="top" align="left" rowspan="1" colspan="1">↑global topology independent structural connectivity (k slope index).</td><td valign="top" align="left" rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">RS-fMRI</td><td valign="top" align="left" rowspan="1" colspan="1">Graph based analysis functional connectomics [FC indices]</td><td valign="top" align="left" rowspan="1" colspan="1">↑global topology independent FC (k slope index)</td><td valign="top" align="left" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tavazzi et al. (<xref rid="B74" ref-type="bibr">2018</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 26</td><td valign="top" align="left" rowspan="1" colspan="1">DWI</td><td valign="top" align="left" rowspan="1" colspan="1">TBSS [FA, MD, RD, AD]</td><td valign="top" align="left" rowspan="1" colspan="1">No results</td><td valign="top" align="left" rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Task-fMRI (plantar dorsiflexion)</td><td valign="top" align="left" rowspan="1" colspan="1">GLM analyses [BOLD maps]</td><td valign="top" align="left" rowspan="1" colspan="1">↓extent of scattered task-based activation</td><td valign="top" align="left" rowspan="1" colspan="1">Motor and premotor areas</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">RS-fMRI</td><td valign="top" align="left" rowspan="1" colspan="1">ICA [FC indices]</td><td valign="top" align="left" rowspan="1" colspan="1">↑resting FC</td><td valign="top" align="left" rowspan="1" colspan="1">pre/post-central Gy bilaterally</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Akbar et al. (<xref rid="B1" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 5 <break/>Con = 5</td><td valign="top" align="left" rowspan="1" colspan="1">RS-fMRI</td><td valign="top" align="left" rowspan="1" colspan="1">Seed-based analysis [FC indices]</td><td valign="top" align="left" rowspan="1" colspan="1">↑FC</td><td valign="top" align="left" rowspan="1" colspan="1">Between caudate and L inferior parietal region, bilateral inferior frontal regions, L middle frontal region, and R insula</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Int: Direct correlation between FC and physical activity level (MFIS)</td><td valign="top" align="left" rowspan="1" colspan="1">Caudate, L inferior parietal</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kjolhede et al. (<xref rid="B34" ref-type="bibr">2018</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 17 <break/>Con = 12</td><td valign="top" align="left" rowspan="1" colspan="1">MPRAGE</td><td valign="top" align="left" rowspan="1" colspan="1">GBV, PBVC [GM volumetry, thickness]</td><td valign="top" align="left" rowspan="1" colspan="1">↑cortical thickness</td><td valign="top" align="left" rowspan="1" colspan="1">Anterior cingulate Gy, temporal pole, orbital Su, and inferior temporal Su following experimental treatment</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Int: correlation between thickness [changes] and clinical data [muscle strength, 5-STS, MSIS, EDSS]</td><td valign="top" align="left" rowspan="1" colspan="1">AC-Gy, AC-Su, Orbital H-shaped Su and Temporal pole</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ibrahim et al. (<xref rid="B28" ref-type="bibr">2011</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 11 MS <break/>HC = 11</td><td valign="top" align="left" rowspan="1" colspan="1">DWI</td><td valign="top" align="left" rowspan="1" colspan="1">DTI [FA, MD, RD, AD]</td><td valign="top" align="left" rowspan="1" colspan="1">↑FA and ↓MD, ↓RD</td><td valign="top" align="left" rowspan="1" colspan="1">CC</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prosperini et al. (<xref rid="B57" ref-type="bibr">2014</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 27</td><td valign="top" align="left" rowspan="1" colspan="1">DWI</td><td valign="top" align="left" rowspan="1" colspan="1">DTI, Streamline tractography [FA, MD, RD, AD]</td><td valign="top" align="left" rowspan="1" colspan="1">↑↓ FA, RD</td><td valign="top" align="left" rowspan="1" colspan="1">Bilateral superior cerebellar peduncle</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Int: correlation between FA/RD and postural sway</td><td valign="top" align="left" rowspan="1" colspan="1">Bilateral superior cerebellar peduncles</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fling et al. (<xref rid="B18" ref-type="bibr">2019</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 14</td><td valign="top" align="left" rowspan="1" colspan="1">RS-fMRI</td><td valign="top" align="left" rowspan="1" colspan="1">ROI-based approach [FC indices]</td><td valign="top" align="left" rowspan="1" colspan="1">↑ FC</td><td valign="top" align="left" rowspan="1" colspan="1">Between the R SMA and the R S1 and between the L SMA and the L S1 as well as the L putamen</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">↓FC</td><td valign="top" align="left" rowspan="1" colspan="1">Between the SMA and multiple regions in the cerebellum including the R Crus I and bilateral Crus II regions</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rasova et al. (<xref rid="B59" ref-type="bibr">2005</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 17 MS <break/>Con = 11 MS <break/>HC = 13</td><td valign="top" align="left" rowspan="1" colspan="1">Task-fMRI (visually cued pinch grasp)</td><td valign="top" align="left" rowspan="1" colspan="1">GLM analyses [BOLD maps]</td><td valign="top" align="left" rowspan="1" colspan="1">No results</td><td valign="top" align="left" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prochazkova et al. (<xref rid="B56" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 18 MS <break/>Con = 17 MS HC = 42</td><td valign="top" align="left" rowspan="1" colspan="1">Task-fMRI (video with first person view of dynamic and static scenes)</td><td valign="top" align="left" rowspan="1" colspan="1">GLM analyses [BOLD maps]</td><td valign="top" align="left" rowspan="1" colspan="1">↑activation</td><td valign="top" align="left" rowspan="1" colspan="1">Cerebellum and R frontal lobe</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Int + Con: Positive correlation with a composite clinical index (based on 9HPT, PASAT, BBS, T25FW, and TUG)</td><td valign="top" align="left" rowspan="1" colspan="1">Cerebellum, SMA, and premotor area</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rasova et al. (<xref rid="B60" ref-type="bibr">2015</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int=12</td><td valign="top" align="left" rowspan="1" colspan="1">DWI</td><td valign="top" align="left" rowspan="1" colspan="1">DTI [FA, MD, RD, AD]</td><td valign="top" align="left" rowspan="1" colspan="1">↑FA and ↓MD</td><td valign="top" align="left" rowspan="1" colspan="1">CC</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Task-fMRI (flex/ext of joints of the hand)</td><td valign="top" align="left" rowspan="1" colspan="1">EC analyses [BOLD maps]</td><td valign="top" align="left" rowspan="1" colspan="1">↓EC (trend only)</td><td valign="top" align="left" rowspan="1" colspan="1">Between SMA and bilateral M1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zuber et al. (<xref rid="B85" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 24 MS <break/>HC = 24</td><td valign="top" align="left" rowspan="1" colspan="1">Task-fMRI (Motor Sequence Learning)</td><td valign="top" align="left" rowspan="1" colspan="1">GLM analyses [BOLD maps]</td><td valign="top" align="left" rowspan="1" colspan="1">↓ motor activation</td><td valign="top" align="left" rowspan="1" colspan="1">L cerebellum and R prefrontal lobe</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Peran et al. (<xref rid="B51" ref-type="bibr">2020</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Int = 26</td><td valign="top" align="left" rowspan="1" colspan="1">Task-fMRI (MSoA, MimA, PassM)</td><td valign="top" align="left" rowspan="1" colspan="1">GLM analyses [BOLD maps]</td><td valign="top" align="left" rowspan="1" colspan="1">↓activation</td><td valign="top" align="left" rowspan="1" colspan="1">Inferior frontal Gy, middle frontal Gy, inferior and superior parietal lobules, pre-SMA, lateral occipital cortex, thalamus</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">↑activation</td><td valign="top" align="left" rowspan="1" colspan="1">AC, Inferior orbital Gy, middle temporal Gy, lingual Gy, calcarine cortex, cuneus and precuneus, middle cingulum, M1 and S1</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">5-STS, 5x sit-to-stand test; 9HPT, 9-hole peg test; AC, anterior cingulum; AD, axial diffusivity; BBS, Berg balance scale; BOLD, blood oxygenation level dependent; CST, corticospinal tract; DTI, diffusion tensor imaging; DWI, diffusion weighted imaging; EC, effective connectivity; EDSS, Expanded Disability Status Scale; FA, fractional anisotropy; FC, functional connectivity; FIM, functional independent measure; fMRI, functional magnetic resonance imaging; Gy, gyrus; GBV, global brain volume; GLM, general linear model; GM, gray matter; HC, healthy control group; ICA, independent component analysis; IFG, inferior frontal gyrus; IHI-MV, inter-hand interval maximal velocity; IHI-SV, inter-hand interval spontaneous velocity; Int, intervention group; M1, primary motor cortex; MD, mean diffusivity; MimA, miming of action; MFIS, Modified fatigue impact scale; MNS, Mirror Neuron System; MSIS, multiple sclerosis impact scale; MSoA, mental simulation of action; PASAT, paced auditory serial addition test; PassM, Passive Movement; PBVC, percentage brain volume change; pCC, posterior part of the Corpus Callosum; RD, radial diffusivity; R-Jamar, right hand muscle strength with Jamar hand dynamometer; RS-fMRI, resting state functional magnetic resonance imaging; Su, sulcus; S1, primary somatosensory cortex; SDMT, symbol digit modality test; SFG, superior frontal gyrus; SMA, supplementary motor area; T25FW, timed 25 foot walk; TBSS, tract-based spatial statistic; TFE, turbo field echo; TUG, Timed up and go; VLMT, verbal learning and memory test; WM, white matter. ↑ means increased; ↓ means decreased</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">MRI characteristic of the studies and significant results.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">References</th><th valign="top" align="left">Subjects included in the MRI study</th><th valign="top" align="left">MR sequences</th><th valign="top" align="left">Post-processing [MRI markers]</th><th valign="top" align="left">MRI significant results+</th><th valign="top" align="left">Brain area of observed changes</th></tr></thead><tbody><tr><td valign="top" align="left">Rocca et al. (???)</td><td valign="top" align="left">Int = 20 MS, 23 HC Con = 21 MS, HC = 23</td><td valign="top" align="left">3D T1 TFE</td><td valign="top" align="left">VBM, TBM [GM volumes]</td><td valign="top" align="left">Int MS vs. Con MS:↑GM volume ↓GM volume</td><td valign="top" align="left">L-MOG, L-SFG, R-IFG SMA</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">Int MS: correlation between clinical and volumes</td><td valign="top" align="left">[R-IFG, R-SFG]</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">Positive correlation: [R-finger tapping, FIM, L Jamar, R Jamar, PASAT] Negative correlation: [PASAT]</td><td valign="top" align="left">[R-SMA]</td></tr><tr><td/><td/><td valign="top" align="left">DWI</td><td valign="top" align="left">TBSS [FA, MD, RD, AD]</td><td valign="top" align="left">No results</td><td/></tr><tr><td/><td/><td valign="top" align="left">RS-fMRI</td><td valign="top" align="left">Seed-based analyses [FC indices]</td><td valign="top" align="left">Int MS vs. Con MS: ↑RS FC Int MS: positive correlation with PASAT</td><td valign="top" align="left">L/R-cerebellum, R-IFG, R-calcarine sulcus Motor and MNS network</td></tr><tr><td/><td/><td valign="top" align="left">Task-fMRI (manipulation task)</td><td valign="top" align="left">GLM analyses [BOLD maps]</td><td valign="top" align="left">Int MS vs. Con MS:↑activation (R hand manipulation) ↑activation (L hand manipulation)</td><td valign="top" align="left">R/L-IFG, L-insula L-FG, R-SFG</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">Int MS correlations: between clinical and fMRI maps of R hand manipulation [R-finger Tapping, R-Jamar, PASAT]</td><td valign="top" align="left">R/L-IFG, L-insula, L-angular, L-MTG</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">Between clinical and fMRI maps of L hand manipulation [PASAT]</td><td valign="top" align="left">R-SFG</td></tr><tr><td valign="top" align="left">Barghi et al. (???)</td><td valign="top" align="left">Int = 10 Con = 10</td><td valign="top" align="left">DWI</td><td valign="top" align="left">TBSS [FA, MD, RD, AD]</td><td valign="top" align="left">↑FA</td><td valign="top" align="left">PCC, SOG</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">↑AD</td><td valign="top" align="left">STG</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">↓RD, MD</td><td valign="top" align="left">CST</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">Int: correlation between FA and motor improvement</td><td valign="top" align="left">CC and SOG</td></tr><tr><td valign="top" align="left">Bonzano et al. (???)</td><td valign="top" align="left">Int = 15 Con = 15</td><td valign="top" align="left">DWI</td><td valign="top" align="left">DTI [FA, MD, RD, AD]</td><td valign="top" align="left">↓FA</td><td valign="top" align="left">CC, CST</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">↑RD</td><td valign="top" align="left">CC, CST</td></tr><tr><td valign="top" align="left">Bonzano et al. (???)</td><td valign="top" align="left">Int = 15 Con = 15</td><td valign="top" align="left">Task-fMRI (finger tapping)</td><td valign="top" align="left">GLM analyses [BOLD maps]</td><td valign="top" align="left">↑activation</td><td valign="top" align="left">R-cerebellum, L-pre/post-central Gy, L-insula</td></tr><tr><td valign="top" align="left">Boffa et al. (???)</td><td valign="top" align="left">Int = 13 Con = 13</td><td valign="top" align="left">DWI</td><td valign="top" align="left">DTI</td><td valign="top" align="left">No results</td><td valign="top" align="left">–</td></tr><tr><td/><td/><td valign="top" align="left">RS-fMRI</td><td valign="top" align="left">Seed-based analysis [FC indices]</td><td valign="top" align="left">↑FC</td><td valign="top" align="left">bilateral thalami and R-cerebellum; cerebellar vermis and R-insula; cerebellar vermis and RSTG</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">Int: Correlation between clinical and FC [IHI-SV, IHI-MV]</td><td valign="top" align="left">R-M1 and R-S1; R/L thalami and R/L IFG; R/L-S1 and L-supramarginal Gy</td></tr><tr><td valign="top" align="left">Stellmann et al. (???)</td><td valign="top" align="left">Int = 27 MS Con = 30 MS HC = 30</td><td valign="top" align="left">DWI</td><td valign="top" align="left">Graph based analysis structural connectomics [FA]</td><td valign="top" align="left">↑global topology independent structural connectivity (k slope index).</td><td valign="top" align="left">–</td></tr><tr><td/><td/><td valign="top" align="left">RS-fMRI</td><td valign="top" align="left">Graph based analysis functional connectomics [FC indices]</td><td valign="top" align="left">↑global topology independent FC (k slope index)</td><td valign="top" align="left">–</td></tr><tr><td valign="top" align="left">Tavazzi et al. (???)</td><td valign="top" align="left">Int = 26</td><td valign="top" align="left">DWI</td><td valign="top" align="left">TBSS [FA, MD, RD, AD]</td><td valign="top" align="left">No results</td><td valign="top" align="left">–</td></tr><tr><td/><td/><td valign="top" align="left">Task-fMRI (plantar dorsiflexion)</td><td valign="top" align="left">GLM analyses [BOLD maps]</td><td valign="top" align="left">↓extent of scattered task-based activation</td><td valign="top" align="left">Motor and premotor areas</td></tr><tr><td/><td/><td valign="top" align="left">RS-fMRI</td><td valign="top" align="left">ICA [FC indices]</td><td valign="top" align="left">↑resting FC</td><td valign="top" align="left">pre/post-central Gy bilaterally</td></tr><tr><td valign="top" align="left">Akbar et al. (???)</td><td valign="top" align="left">Int = 5 Con = 5</td><td valign="top" align="left">RS-fMRI</td><td valign="top" align="left">Seed-based analysis [FC indices]</td><td valign="top" align="left">↑FC</td><td valign="top" align="left">Between caudate and L inferior parietal region, bilateral inferior frontal regions, L middle frontal region, and R insula</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">Int: Direct correlation between FC and physical activity level (MFIS)</td><td valign="top" align="left">Caudate, L inferior parietal</td></tr><tr><td valign="top" align="left">Kjolhede et al. (???)</td><td valign="top" align="left">Int = 17 Con = 12</td><td valign="top" align="left">MPRAGE</td><td valign="top" align="left">GBV, PBVC [GM volumetry, thickness]</td><td valign="top" align="left">↑cortical thickness</td><td valign="top" align="left">Anterior cingulate Gy, temporal pole, orbital Su, and inferior temporal Su following experimental treatment</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">Int: correlation between thickness [changes] and clinical data [muscle strength, 5-STS, MSIS, EDSS]</td><td valign="top" align="left">AC-Gy, AC-Su, Orbital H-shaped Su and Temporal pole</td></tr><tr><td valign="top" align="left">Ibrahim et al. (???)</td><td valign="top" align="left">Int = 11 MS HC = 11</td><td valign="top" align="left">DWI</td><td valign="top" align="left">DTI [FA, MD, RD, AD]</td><td valign="top" align="left">↑FA and ↓MD, ↓RD</td><td valign="top" align="left">CC</td></tr><tr><td valign="top" align="left">Prosperini et al. (???)</td><td valign="top" align="left">Int = 27</td><td valign="top" align="left">DWI</td><td valign="top" align="left">DTI, Streamline tractography [FA, MD, RD, AD]</td><td valign="top" align="left">↑↓ FA, RD</td><td valign="top" align="left">Bilateral superior cerebellar peduncle</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">Int: correlation between FA/RD and postural sway</td><td valign="top" align="left">Bilateral superior cerebellar peduncles</td></tr><tr><td valign="top" align="left">Fling et al. (???)</td><td valign="top" align="left">Int = 14</td><td valign="top" align="left">RS-fMRI</td><td valign="top" align="left">ROI-based approach [FC indices]</td><td valign="top" align="left">↑ FC</td><td valign="top" align="left">Between the R SMA and the R S1 and between the L SMA and the L S1 as well as the L putamen</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">↓FC</td><td valign="top" align="left">Between the SMA and multiple regions in the cerebellum including the R Crus I and bilateral Crus II regions</td></tr><tr><td valign="top" align="left">Rasova et al. (???)</td><td valign="top" align="left">Int = 17 MS Con = 11 MS HC = 13</td><td valign="top" align="left">Task-fMRI (visually cued pinch grasp)</td><td valign="top" align="left">GLM analyses [BOLD maps]</td><td valign="top" align="left">No results</td><td valign="top" align="left">–</td></tr><tr><td valign="top" align="left">Prochazkova et al. (???)</td><td valign="top" align="left">Int = 18 MS Con = 17 MS HC = 42</td><td valign="top" align="left">Task-fMRI (video with first person view of dynamic and static scenes)</td><td valign="top" align="left">GLM analyses [BOLD maps]</td><td valign="top" align="left">↑activation</td><td valign="top" align="left">Cerebellum and R frontal lobe</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">Int + Con: Positive correlation with a composite clinical index (based on 9HPT, PASAT, BBS, T25FW, and TUG)</td><td valign="top" align="left">Cerebellum, SMA, and premotor area</td></tr><tr><td valign="top" align="left">Rasova et al. (???)</td><td valign="top" align="left">Int=12</td><td valign="top" align="left">DWI</td><td valign="top" align="left">DTI [FA, MD, RD, AD]</td><td valign="top" align="left">↑FA and ↓MD</td><td valign="top" align="left">CC</td></tr><tr><td/><td/><td valign="top" align="left">Task-fMRI (flex/ext of joints of the hand)</td><td valign="top" align="left">EC analyses [BOLD maps]</td><td valign="top" align="left">↓EC (trend only)</td><td valign="top" align="left">Between SMA and bilateral M1</td></tr><tr><td valign="top" align="left">Zuber et al. (???)</td><td valign="top" align="left">Int = 24 MS HC = 24</td><td valign="top" align="left">Task-fMRI (Motor Sequence Learning)</td><td valign="top" align="left">GLM analyses [BOLD maps]</td><td valign="top" align="left">↓ motor activation</td><td valign="top" align="left">L cerebellum and R prefrontal lobe</td></tr><tr><td valign="top" align="left">Peran et al. (???)</td><td valign="top" align="left">Int = 26</td><td valign="top" align="left">Task-fMRI (MSoA, MimA, PassM)</td><td valign="top" align="left">GLM analyses [BOLD maps]</td><td valign="top" align="left">↓activation</td><td valign="top" align="left">Inferior frontal Gy, middle frontal Gy, inferior and superior parietal lobules, pre-SMA, lateral occipital cortex, thalamus</td></tr><tr><td/><td/><td/><td/><td valign="top" align="left">↑activation</td><td valign="top" align="left">AC, Inferior orbital Gy, middle temporal Gy, lingual Gy, calcarine cortex, cuneus and precuneus, middle cingulum, M1 and S1</td></tr></tbody></table></div>5-STS, 5x sit-to-stand test; 9HPT, 9-hole peg test; AC, anterior cingulum; AD, axial diffusivity; BBS, Berg balance scale; BOLD, blood oxygenation level dependent; CST, corticospinal tract; DTI, diffusion tensor imaging; DWI, diffusion weighted imaging; EC, effective connectivity; EDSS, Expanded Disability Status Scale; FA, fractional anisotropy; FC, functional connectivity; FIM, functional independent measure; fMRI, functional magnetic resonance imaging; Gy, gyrus; GBV, global brain volume; GLM, general linear model; GM, gray matter; HC, healthy control group; ICA, independent component analysis; IFG, inferior frontal gyrus; IHI-MV, inter-hand interval maximal velocity; IHI-SV, inter-hand interval spontaneous velocity; Int, intervention group; M1, primary motor cortex; MD, mean diffusivity; MimA, miming of action; MFIS, Modified fatigue impact scale; MNS, Mirror Neuron System; MSIS, multiple sclerosis impact scale; MSoA, mental simulation of action; PASAT, paced auditory serial addition test; PassM, Passive Movement; PBVC, percentage brain volume change; pCC, posterior part of the Corpus Callosum; RD, radial diffusivity; R-Jamar, right hand muscle strength with Jamar hand dynamometer; RS-fMRI, resting state functional magnetic resonance imaging; Su, sulcus; S1, primary somatosensory cortex; SDMT, symbol digit modality test; SFG, superior frontal gyrus; SMA, supplementary motor area; T25FW, timed 25 foot walk; TBSS, tract-based spatial statistic; TFE, turbo field echo; TUG, Timed up and go; VLMT, verbal learning and memory test; WM, white matter. ↑ means increased; ↓ means decreased.</transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>Table 3</table-label><table-caption>TESTEX evaluation.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="T3"><label>Table 3</label><caption><p>TESTEX evaluation.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1"><bold>Scores</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Rocca et al. (<xref rid="B62" ref-type="bibr">2019</xref>)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Barghi et al. (<xref rid="B2" ref-type="bibr">2018</xref>)<xref rid="TN7" ref-type="table-fn"><sup>§</sup></xref></bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Bonzano et al. (<xref rid="B9" ref-type="bibr">2014</xref>)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Bonzano et al. (<xref rid="B8" ref-type="bibr">2019</xref>)<xref rid="TN7" ref-type="table-fn"><sup>§</sup></xref></bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Boffa et al. (<xref rid="B7" ref-type="bibr">2020</xref>)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Stellmann et al. (<xref rid="B70" ref-type="bibr">2020</xref>)<xref rid="TN7" ref-type="table-fn"><sup>§</sup></xref></bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Tavazzi et al. (<xref rid="B74" ref-type="bibr">2018</xref>)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Kjolhede et al. (<xref rid="B34" ref-type="bibr">2018</xref>)<xref rid="TN7" ref-type="table-fn"><sup>§</sup></xref></bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Prosperini et al. (<xref rid="B57" ref-type="bibr">2014</xref>)</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Fling et al. (<xref rid="B18" ref-type="bibr">2019</xref>)<xref rid="TN8" ref-type="table-fn"><sup>#</sup></xref></bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Prochazkova et al. (<xref rid="B56" ref-type="bibr">2020</xref>) <xref rid="TN7" ref-type="table-fn"><sup>§</sup></xref></bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Study quality</td><td valign="top" align="left" rowspan="1" colspan="1">Eligibility criteria</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Randomization</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Allocation concealment</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Similarity at baseline</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">NA/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Blinding of assessors</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1<xref rid="TN5" ref-type="table-fn"><sup>°</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1<xref rid="TN5" ref-type="table-fn"><sup>°</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1<xref rid="TN5" ref-type="table-fn"><sup>°</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1<xref rid="TN6" ref-type="table-fn"><sup>%</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Study reporting</td><td valign="top" align="left" rowspan="1" colspan="1">Outcome measures (85% patients)</td><td valign="top" align="left" rowspan="1" colspan="1">1/3</td><td valign="top" align="left" rowspan="1" colspan="1">2/3</td><td valign="top" align="left" rowspan="1" colspan="1">1/3</td><td valign="top" align="left" rowspan="1" colspan="1">2/3</td><td valign="top" align="left" rowspan="1" colspan="1">1/3</td><td valign="top" align="left" rowspan="1" colspan="1">2/3</td><td valign="top" align="left" rowspan="1" colspan="1">2/3</td><td valign="top" align="left" rowspan="1" colspan="1">2/3</td><td valign="top" align="left" rowspan="1" colspan="1">2/3</td><td valign="top" align="left" rowspan="1" colspan="1">2/3</td><td valign="top" align="left" rowspan="1" colspan="1">1/3</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Intention to treat</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Between group statistical comparison</td><td valign="top" align="left" rowspan="1" colspan="1">2/2</td><td valign="top" align="left" rowspan="1" colspan="1">1/2</td><td valign="top" align="left" rowspan="1" colspan="1">2/2</td><td valign="top" align="left" rowspan="1" colspan="1">1/2</td><td valign="top" align="left" rowspan="1" colspan="1">2/2</td><td valign="top" align="left" rowspan="1" colspan="1">2/2</td><td valign="top" align="left" rowspan="1" colspan="1">NA/2</td><td valign="top" align="left" rowspan="1" colspan="1">2/2</td><td valign="top" align="left" rowspan="1" colspan="1">1/2</td><td valign="top" align="left" rowspan="1" colspan="1">2/2</td><td valign="top" align="left" rowspan="1" colspan="1">2/2</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Point measure and measure of variability</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Activity monitoring in the control group<xref rid="TN4" ref-type="table-fn"><sup>**</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Increased exercise intensity</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">0/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Exercise parameters</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td><td valign="top" align="left" rowspan="1" colspan="1">1/1</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Total score</td><td valign="top" align="left" rowspan="1" colspan="1">10/15<xref rid="TN3" ref-type="table-fn"><sup>*</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">8/15<xref rid="TN3" ref-type="table-fn"><sup>*</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">10/15</td><td valign="top" align="left" rowspan="1" colspan="1">9/15</td><td valign="top" align="left" rowspan="1" colspan="1">9/15<xref rid="TN3" ref-type="table-fn"><sup>*</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">12/15<xref rid="TN3" ref-type="table-fn"><sup>*</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">7/15</td><td valign="top" align="left" rowspan="1" colspan="1">12/15<xref rid="TN3" ref-type="table-fn"><sup>*</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">9/15<xref rid="TN3" ref-type="table-fn"><sup>*</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">12/15</td><td valign="top" align="left" rowspan="1" colspan="1">9/15</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">NA, not applicable</italic>.</p><fn id="TN3"><label>*</label><p><italic toggle="yes">Study characteristics were retrieved from reference protocol trials or previous/pilot studies from the same group</italic>.</p></fn><fn id="TN4"><label>**</label><p><italic toggle="yes">The point was assigned also for studies in which the physiotherapy of the control group was either delivered (as in the case of passive mobilization training), or supervised by a physiotherapist. For studies including waitlisted control groups, we awarded 1 point only if any kind of monitoring was specified (e.g., daily exercise diary)</italic>.</p></fn><fn id="TN5"><label>°</label><p><italic toggle="yes">Blinding of the MRI evaluators and MRI was listed as primary aim of the study</italic>.</p></fn><fn id="TN6"><label>%</label><p><italic toggle="yes">Blinding of the MRI evaluators was not reported and MRI was listed as primary aim of the study</italic>.</p></fn><fn id="TN7"><label>§</label><p><italic toggle="yes">Registered randomized controlled trial</italic>.</p></fn><fn id="TN8"><label>#</label><p><italic toggle="yes">Points were determined based on the original registered randomized controlled trial</italic>.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">TESTEX evaluation.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th valign="top" align="left">Scores</th><th valign="top" align="left">Rocca et al. (???)</th><th valign="top" align="left">Barghi et al. (???)???</th><th valign="top" align="left">Bonzano et al. (???)</th><th valign="top" align="left">Bonzano et al. (???)???</th><th valign="top" align="left">Boffa et al. (???)</th><th valign="top" align="left">Stellmann et al. (???)???</th><th valign="top" align="left">Tavazzi et al. (???)</th><th valign="top" align="left">Kjolhede et al. (???)???</th><th valign="top" align="left">Prosperini et al. (???)</th><th valign="top" align="left">Fling et al. (???)???</th><th valign="top" align="left">Prochazkova et al. (???) ???</th></tr></thead><tbody><tr><td valign="top" align="left">Study quality</td><td valign="top" align="left">Eligibility criteria</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td></tr><tr><td/><td valign="top" align="left">Randomization</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td></tr><tr><td/><td valign="top" align="left">Allocation concealment</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td></tr><tr><td/><td valign="top" align="left">Similarity at baseline</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">NA/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td></tr><tr><td/><td valign="top" align="left">Blinding of assessors</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1???</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1???</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1???</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1???</td></tr><tr><td valign="top" align="left">Study reporting</td><td valign="top" align="left">Outcome measures (85% patients)</td><td valign="top" align="left">1/3</td><td valign="top" align="left">2/3</td><td valign="top" align="left">1/3</td><td valign="top" align="left">2/3</td><td valign="top" align="left">1/3</td><td valign="top" align="left">2/3</td><td valign="top" align="left">2/3</td><td valign="top" align="left">2/3</td><td valign="top" align="left">2/3</td><td valign="top" align="left">2/3</td><td valign="top" align="left">1/3</td></tr><tr><td/><td valign="top" align="left">Intention to treat</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td></tr><tr><td/><td valign="top" align="left">Between group statistical comparison</td><td valign="top" align="left">2/2</td><td valign="top" align="left">1/2</td><td valign="top" align="left">2/2</td><td valign="top" align="left">1/2</td><td valign="top" align="left">2/2</td><td valign="top" align="left">2/2</td><td valign="top" align="left">NA/2</td><td valign="top" align="left">2/2</td><td valign="top" align="left">1/2</td><td valign="top" align="left">2/2</td><td valign="top" align="left">2/2</td></tr><tr><td/><td valign="top" align="left">Point measure and measure of variability</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td></tr><tr><td/><td valign="top" align="left">Activity monitoring in the control group???</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td></tr><tr><td/><td valign="top" align="left">Increased exercise intensity</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">0/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td></tr><tr><td/><td valign="top" align="left">Exercise parameters</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td><td valign="top" align="left">1/1</td></tr><tr><td/><td valign="top" align="left">Total score</td><td valign="top" align="left">10/15???</td><td valign="top" align="left">8/15???</td><td valign="top" align="left">10/15</td><td valign="top" align="left">9/15</td><td valign="top" align="left">9/15???</td><td valign="top" align="left">12/15???</td><td valign="top" align="left">7/15</td><td valign="top" align="left">12/15???</td><td valign="top" align="left">9/15???</td><td valign="top" align="left">12/15</td><td valign="top" align="left">9/15</td></tr></tbody></table></div>NA, not applicable.*Study characteristics were retrieved from reference protocol trials or previous/pilot studies from the same group.**The point was assigned also for studies in which the physiotherapy of the control group was either delivered (as in the case of passive mobilization training), or supervised by a physiotherapist. For studies including waitlisted control groups, we awarded 1 point only if any kind of monitoring was specified (e.g., daily exercise diary).°Blinding of the MRI evaluators and MRI was listed as primary aim of the study.%Blinding of the MRI evaluators was not reported and MRI was listed as primary aim of the study.§Registered randomized controlled trial.#Points were determined based on the original registered randomized controlled trial.</transformed-table></extracted-table></extracted-tables-set>